EphB2-dependent signaling promotes neuronal excitotoxicity and inflammation in the acute phase of ischemic stroke
暂无分享,去创建一个
S. Heiland | M. Hecker | M. Bendszus | C. Sticht | H. Bading | Anna M. Hagenston | T. Korff | H. H. Marti | M. Bendszus | A. Ernst | Laura-Inés Böhler | R. Kunze | A. Hoffmann
[1] W. Xu,et al. EphrinB2 activation enhances angiogenesis, reduces amyloid-β deposits and secondary damage in thalamus at the early stage after cortical infarction in hypertensive rats , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] A. Obenaus,et al. Functional Consequences of Synapse Remodeling Following Astrocyte-Specific Regulation of Ephrin-B1 in the Adult Hippocampus , 2018, The Journal of Neuroscience.
[3] M. Tymianski,et al. Targeting NMDA receptors in stroke: new hope in neuroprotection , 2018, Molecular Brain.
[4] DeppConstanze,et al. Synaptic Activity Protects Neurons Against Calcium-Mediated Oxidation and Contraction of Mitochondria During Excitotoxicity , 2017 .
[5] Daniel S Spellman,et al. Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain , 2017, PLoS biology.
[6] M. Endres,et al. EphrinB2 Activation Enhances Vascular Repair Mechanisms and Reduces Brain Swelling After Mild Cerebral Ischemia , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[7] H. Bading. Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations , 2017, The Journal of experimental medicine.
[8] H. H. Marti,et al. Neuronal HIF-1α and HIF-2α deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] J. Faber,et al. Variants of Rab GTPase–Effector Binding Protein-2 Cause Variation in the Collateral Circulation and Severity of Stroke , 2016, Stroke.
[10] H. H. Marti,et al. Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner , 2016, Neurobiology of Disease.
[11] A. Kania,et al. Mechanisms of ephrin–Eph signalling in development, physiology and disease , 2016, Nature Reviews Molecular Cell Biology.
[12] J. Simard,et al. Molecular pathophysiology of cerebral edema , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] Y. Koyama,et al. Pathogenesis of Brain Edema and Investigation into Anti-Edema Drugs , 2015, International journal of molecular sciences.
[14] B. MacVicar,et al. The Cellular Mechanisms of Neuronal Swelling Underlying Cytotoxic Edema , 2015, Cell.
[15] L. Raymond,et al. Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders , 2014, Neuron.
[16] Y. T. Wang,et al. Excitotoxicity and stroke: Identifying novel targets for neuroprotection , 2014, Progress in Neurobiology.
[17] Hui Liu,et al. EphrinB-mediated reverse signalling controls junctional integrity and pro-inflammatory differentiation of endothelial cells , 2014, Thrombosis and Haemostasis.
[18] Lexiao Li,et al. Inhibition of HIF prolyl-4-hydroxylases by FG-4497 Reduces Brain Tissue Injury and Edema Formation during Ischemic Stroke , 2014, PloS one.
[19] Wei Zhou,et al. Neuron-Specific Prolyl-4-Hydroxylase Domain 2 Knockout Reduces Brain Injury After Transient Cerebral Ischemia , 2012, Stroke.
[20] Xin Wei,et al. Tight Junction in Blood‐Brain Barrier: An Overview of Structure, Regulation, and Regulator Substances , 2012, CNS neuroscience & therapeutics.
[21] B. Han,et al. Ephrinb1 and Ephrinb2 Are Associated with Interleukin-7 Receptor α and Retard Its Internalization from the Cell Surface* , 2011, The Journal of Biological Chemistry.
[22] D. Hermann,et al. Enhancement of endogenous neurogenesis in ephrin-B3 deficient mice after transient focal cerebral ischemia , 2011, Acta Neuropathologica.
[23] M. Dalva,et al. EphB Controls NMDA Receptor Function and Synaptic Targeting in a Subunit-Specific Manner , 2011, The Journal of Neuroscience.
[24] M. Schwaninger,et al. A Signaling Cascade of Nuclear Calcium-CREB-ATF3 Activated by Synaptic NMDA Receptors Defines a Gene Repression Module That Protects against Extrasynaptic NMDA Receptor-Induced Neuronal Cell Death and Ischemic Brain Damage , 2011, The Journal of Neuroscience.
[25] T. Ludwig,et al. Endothelial Cell EphrinB2-Dependent Activation of Monocytes in Arteriosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[26] H. Bading,et al. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders , 2010, Nature Reviews Neuroscience.
[27] N. Pivovarova,et al. Calcium‐dependent mitochondrial function and dysfunction in neurons , 2010, The FEBS journal.
[28] Guohong Li,et al. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells , 2010, Journal of leukocyte biology.
[29] G. Hardingham. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. , 2009, Biochemical Society transactions.
[30] Hilmar Bading,et al. Nuclear Calcium Signaling Controls Expression of a Large Gene Pool: Identification of a Gene Program for Acquired Neuroprotection Induced by Synaptic Activity , 2009, PLoS genetics.
[31] C. Winters,et al. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity , 2009, Proceedings of the National Academy of Sciences.
[32] Christian Gerloff,et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. , 2009, Stroke.
[33] G. Mealing,et al. Elevated Synaptic Activity Preconditions Neurons against an in Vitro Model of Ischemia* , 2008, Journal of Biological Chemistry.
[34] H. Augustin,et al. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes , 2008, Journal of Cell Science.
[35] Karin E. Sandoval,et al. Blood-brain barrier tight junction permeability and ischemic stroke , 2008, Neurobiology of Disease.
[36] Q. Hou,et al. Blockade of EphB2 enhances neurogenesis in the subventricular zone and improves neurological function after cerebral cortical infarction in hypertensive rats , 2008, Brain Research.
[37] H. Augustin,et al. Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment. , 2008, Blood.
[38] K. Hayashi,et al. Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis. , 2008, Clinical science.
[39] Elena B Pasquale,et al. Eph-Ephrin Bidirectional Signaling in Physiology and Disease , 2008, Cell.
[40] E. Ling,et al. Blood brain barrier in hypoxic-ischemic conditions. , 2008, Current neurovascular research.
[41] J. Simard,et al. Cytotoxic edema: mechanisms of pathological cell swelling. , 2007, Neurosurgical focus.
[42] E. Levine,et al. Changes in secondary glutamate release underlie the developmental regulation of excitotoxic neuronal cell death , 2005, Neuroscience.
[43] R. Myers,et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.
[44] J. Mesirov,et al. From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .
[45] J. Tremblay,et al. EphB6-null mutation results in compromised T cell function. , 2004, The Journal of clinical investigation.
[46] E. Pasquale,et al. Eph receptors in the adult brain , 2004, Current Opinion in Neurobiology.
[47] L. F. Kromer,et al. Ephrin-B2 and EphB2 Regulation of Astrocyte-Meningeal Fibroblast Interactions in Response to Spinal Cord Lesions in Adult Rats , 2003, The Journal of Neuroscience.
[48] Yulian Wu,et al. EphB6 crosslinking results in costimulation of T cells. , 2002, The Journal of clinical investigation.
[49] H. Bading,et al. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways , 2002, Nature Neuroscience.
[50] T. Bonhoeffer,et al. Kinase-Independent Requirement of EphB2 Receptors in Hippocampal Synaptic Plasticity , 2001, Neuron.
[51] M. Dalva,et al. Modulation of NMDA Receptor- Dependent Calcium Influx and Gene Expression Through EphB Receptors , 2001, Science.
[52] Michael E Greenberg,et al. EphB Receptors Interact with NMDA Receptors and Regulate Excitatory Synapse Formation , 2000, Cell.
[53] M. Moskowitz,et al. Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.
[54] O. Kretz,et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety , 1999, Nature Genetics.
[55] A. Bacci,et al. Synaptogenesis in hippocampal cultures , 1999, Cellular and Molecular Life Sciences CMLS.
[56] F. Diella,et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.
[57] T. Pawson,et al. Nuk Controls Pathfinding of Commissural Axons in the Mammalian Central Nervous System , 1996, Cell.
[58] L. Pitts,et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.
[59] M. Frotscher,et al. Hippocampal plasticity requires postsynaptic ephrinBs , 2004, Nature Neuroscience.